drugset / Trial / NCT01169714
A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.
RandomizedParallel-groupDouble-blind
Summary
This study is designed to observe the safety and blood concentrations of PF-04995274 during and following the administration of multiple doses of PF-04995274 for a duration of 14 days, in healthy adult and healthy elderly.
Timeline
- Start
- 2010-08
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04995274 | Small molecule | 0.1 mg | — |
| Subject | PF-04995274 | Small molecule | 1 mg | — |
| Subject | PF-04995274 | Small molecule | 10 mg | — |
| Subject | PF-04995274 | Small molecule | 15 mg | — |
Indications
No indication recorded.